Literature DB >> 33363654

THYROID DISORDERS PREVALENCE IN A COHORT OF KIDNEY TRANSPLANT RECIPIENTS.

S Karakose1, I Cordan2, G Gonulalan3, M Karakose2, P O Kurtgoz1, I Baloglu4, K Turkmen4, I Guney1.   

Abstract

CONTEXT: As the life expectancy prolongs, malignancy has become an important issue in renal transplant recipients (RTRs). Thyroid cancer is the most common endocrine malignancy with ongoing increase in incidence all over the world. OBJECTIVE AND
DESIGN: This is a cross-sectional study that investigates the thyroid disorders and the prevalence of thyroid nodule and cancer in RTRs. SUBJECTS AND METHODS: 204 RTRs were evaluated for the thyroid diseases with ultrasonography, serum thyroid stimulating hormone, free T4, free T3 levels, anti-thyroglobulin antibody and anti-thyroid peroxidase antibody levels; FNAB was carried if required.
RESULTS: 191 patients (94.1%) had normal thyroid function. Subclinical hypothyroidism was diagnosed in 11 patients, subclinical hyperthyroidism in 1 patient and low T3 syndrome in 4 patients. The FNAB was performed in 17 (27.9%) from 61 patients with thyroid nodule. The cytological examination of biopsy materials revealed that 2 (11.8%) nodules were suspicious for malignancy, 13 (76.5%) were benign, and 2 (11.8%) with non diagnostic cytology. Thyroid cancer prevalence was 0.2% in Turkey but we detected that 0.98% of RTRs had thyroid cancer.
CONCLUSIONS: Screening the RTRs for thyroid disorders is necessary, so that early diagnosis and appropriate treatment of thyroid disease and cancer may improve the quality of life. ©by Acta Endocrinologica Foundation.

Entities:  

Keywords:  renal transplant; thyroid cancer; thyroid dysfunction

Year:  2020        PMID: 33363654      PMCID: PMC7748240          DOI: 10.4183/aeb.2020.324

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   0.877


  27 in total

Review 1.  Clinical practice. The thyroid nodule.

Authors:  Laszlo Hegedüs
Journal:  N Engl J Med       Date:  2004-10-21       Impact factor: 91.245

2.  Incidence of thyroid dysfunction and thyroid cancer in renal transplant recipients: a single center experience.

Authors:  Ozkan Gungor; Ali Celik; Levent Kebapcilar; Oguzhan Karaoglu; Sibel Ersan; Koray Atilla; Tulay Canda; Firat Bayraktar; Sena Yesil
Journal:  Ren Fail       Date:  2010-01       Impact factor: 2.606

3.  Effect of immunosuppression for primary renal disease on the risk of cancer in subsequent renal transplantation: a population-based retrospective cohort study.

Authors:  Adrian D Hibberd; Paul R Trevillian; John H Wlodarczyk; Dante G Kemp; Ann M Stein; Alastair H B Gillies; Munish K Heer; Anslie G R Sheil
Journal:  Transplantation       Date:  2013-01-15       Impact factor: 4.939

4.  Papillary microcarcinoma of the thyroid gland in renal transplant patients.

Authors:  B Nemes; A Zalatnai; H Podder; J Járay; P Sótonyi; Z Schaff; K Földes; F Perner
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

5.  Thyroid cancer in the thyroid nodules evaluated by ultrasonography and fine-needle aspiration cytology.

Authors:  Jen-Der Lin; Tzu-Chieh Chao; Bie-Yu Huang; Szu-Tah Chen; Hung-Yu Chang; Chuen Hsueh
Journal:  Thyroid       Date:  2005-07       Impact factor: 6.568

6.  Thyroid function and morphology after a successful kidney transplantation.

Authors:  L Tauchmanovà; R Carrano; T Musella; F Orio; M Sabbatini; G Lombardi; G Fenzi; S Federico; A Colao
Journal:  J Endocrinol Invest       Date:  2006 Jul-Aug       Impact factor: 4.256

7.  Cancer incidence among Canadian kidney transplant recipients.

Authors:  P J Villeneuve; D E Schaubel; S S Fenton; F A Shepherd; Y Jiang; Y Mao
Journal:  Am J Transplant       Date:  2007-02-28       Impact factor: 8.086

8.  Evaluation of thyroid nodules in Turkish population.

Authors:  Serdal Ugurlu; Erkan Caglar; Tijen Erdem Yesim; Eda Tanrikulu; Gunay Can; Pinar Kadioglu
Journal:  Intern Med       Date:  2008-02-15       Impact factor: 1.271

Review 9.  Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infection.

Authors:  Roberto Marcén
Journal:  Drugs       Date:  2009-11-12       Impact factor: 9.546

10.  Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQITM) conference.

Authors:  Michael Abecassis; Stephen T Bartlett; Allan J Collins; Connie L Davis; Francis L Delmonico; John J Friedewald; Rebecca Hays; Andrew Howard; Edward Jones; Alan B Leichtman; Robert M Merion; Robert A Metzger; Francoise Pradel; Eugene J Schweitzer; Ruben L Velez; Robert S Gaston
Journal:  Clin J Am Soc Nephrol       Date:  2008-02-06       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.